Interventional Cardiology & Surgery
Conference Coverage
In early days, bioabsorbable stent rivals nonabsorbable devices
Late lumen loss with a new bioabsorbable drug-eluting stent is on par with nonabsorbable devices in early data.
20th Anniversary
20 years of clinical research in cardiology
“It’s unbelievable how much we’ve accomplished in the last 20 years” in cardiology, said Dr. Steven E. Nissen.
Conference Coverage
Long-term BP reductions with renal denervation not race specific
Long-term blood pressure reductions in the Black patient cohort of the SYMPLICITY renal denervation trial challenge early results.
Latest News
Med center and top cardio surgeon must pay $8.5 million for fraud, concurrent surgeries
A lawsuit alleges that James L. Luketich, MD, regularly performed up to three complex surgical procedures simultaneously.
Conference Coverage
Mini-invasive MV repair as safe, effective as sternotomy surgery but has advantages: UK Mini-Mitral Trial
Patient recovery at 12 weeks and safety outcomes were similar for the two techniques in patients with degenerative mitral valve disease. But the...
Conference Coverage
BIOVASC: Immediate complete revascularization beneficial in ACS
Immediate complete revascularization during the index procedure might become the new treatment paradigm in patients with ACS and multivessel...
Conference Coverage
When intravascular imaging guides complex PCI, MACE risk is lowered
In stent placement for complex coronary lesions, intravascular imaging reduces events relative to angiography.
Conference Coverage
Viability-guided PCI doubted in stable severe CAD: REVIVED-BCIS2
Is myocardial viability testing for guiding PCI decisions currently used in the best way? A secondary analysis from the main trial suggests not....
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...
Conference Coverage
Transcatheter tricuspid valve repair effective and safe for regurgitation
In a randomized pivotal trial, a percutaneous repair of tricuspid valve regurgitation was effective and safe.
Conference Coverage
At 5 years, TAVI valves perform better than surgical ones
TAVR valves deteriorate less than surgical valves at 5 years in patients treated for severe aortic stenosis.